Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Estrella Immunopharma ( (ESLA) ) has provided an announcement.
Estrella Immunopharma, Inc. announced that it has regained compliance with Nasdaq’s listing requirements as of September 23, 2025. The company met the minimum bid price and market value of listed securities requirements, resolving previous non-compliance issues and stabilizing its position on the Nasdaq Stock Market.
The most recent analyst rating on (ESLA) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Estrella Immunopharma stock, see the ESLA Stock Forecast page.
More about Estrella Immunopharma
Average Trading Volume: 24,674
Technical Sentiment Signal: Hold
Current Market Cap: $44.48M
For a thorough assessment of ESLA stock, go to TipRanks’ Stock Analysis page.